Mei Hong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mei Hong has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Meng Liu
Department of Cardiology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
6 shared publicationsYi Li
Department of Cardiology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
4 shared publicationsHao He
Department of Cardiology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, China
3 shared publicationsLin Kuai
Department of Cardiology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, China
3 shared publicationsMingyue Chen
Department of Cardiology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, China
3 shared publicationsFang-Ping Xiao
Department of Cardiology, Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
2 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (27) , e49554
Association between blood cadmium and prevalent coronary heart disease in NHANES 2013 to 2014: A cross-sectional study with machine-learning analyses
Cadmium is a toxic environmental metal, but its association with prevalent coronary heart disease (CHD) remains uncertain. We examined whether blood cadmium concentrations were associated with prevalent CHD in US adults and explored machine-learning model performance. This cross-sectional study used data from the National Health and Nutrition Examination Survey 2013 to 2014. Adults aged ≥20 years with complete data on self-reported CHD, blood cadmium, and covariates were included. Blood cadmium was measured by inductively coupled plasma mass spectrometry. Survey-weighted logistic regression was used to assess associations between blood cadmium and prevalent CHD. Sensitivity analyses additionally adjusted for serum cotinine and were repeated in never smokers. Ten machine-learning algorithms were developed to assess discrimination, calibration, and feature importance. Among 2219 participants, higher blood cadmium concentrations were associated with higher odds of prevalent CHD. In the fully adjusted model, each 1-unit increase in ln-transformed blood cadmium was associated with prevalent CHD (odds ratio, 1.38; 95% confidence interval, 1.05–1.81). Compared with the lowest quartile, the highest quartile was associated with higher odds of prevalent CHD (odds ratio, 1.95; 95% confidence interval, 1.25–3.04). The association remained after additional adjustment for serum cotinine but was attenuated in never smokers. The multilayer perceptron showed the best overall discrimination and calibration; age ranked first and blood cadmium ranked second by mean absolute Shapley Additive Explanations value. Higher blood cadmium concentrations were associated with higher odds of prevalent CHD in this cross-sectional analysis. These findings should be interpreted cautiously because residual smoking-related confounding remains possible and the CHD outcome was self-reported.
- 3 July 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (27) , e49554
Open AccessAssociation between blood cadmium and prevalent coronary heart disease in NHANES 2013 to 2014: A cross-sectional study with machine-learning analyses
Cadmium is a toxic environmental metal, but its association with prevalent coronary heart disease (CHD) remains uncertain. We examined whether blood cadmium concentrations were associated with prevalent CHD in US adults and explored machine-learning model performance. This cross-sectional study used data from the National Health and Nutrition Examination Survey 2013 to 2014. Adults aged ≥20 years with complete data on self-reported CHD, blood cadmium, and covariates were included. Blood cadmium was measured by inductively coupled plasma mass spectrometry. Survey-weighted logistic regression was used to assess associations between blood cadmium and prevalent CHD. Sensitivity analyses additionally adjusted for serum cotinine and were repeated in never smokers. Ten machine-learning algorithms were developed to assess discrimination, calibration, and feature importance. Among 2219 participants, higher blood cadmium concentrations were associated with higher odds of prevalent CHD. In the fully adjusted model, each 1-unit increase in ln-transformed blood cadmium was associated with prevalent CHD (odds ratio, 1.38; 95% confidence interval, 1.05–1.81). Compared with the lowest quartile, the highest quartile was associated with higher odds of prevalent CHD (odds ratio, 1.95; 95% confidence interval, 1.25–3.04). The association remained after additional adjustment for serum cotinine but was attenuated in never smokers. The multilayer perceptron showed the best overall discrimination and calibration; age ranked first and blood cadmium ranked second by mean absolute Shapley Additive Explanations value. Higher blood cadmium concentrations were associated with higher odds of prevalent CHD in this cross-sectional analysis. These findings should be interpreted cautiously because residual smoking-related confounding remains possible and the CHD outcome was self-reported.
- 18 June 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1872 (7) , 168327
The CFIm25/FDPs axis orchestrates protective mitophagy in macrophages to attenuate myocardial infarction
- 18 June 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1872 (7) , 168327
The CFIm25/FDPs axis orchestrates protective mitophagy in macrophages to attenuate myocardial infarction
- Open Access
- 1 January 2024
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 21 (3) , 562-570
Predictive Value of CFIm25 Expression in Peripheral Blood Monocytes for Coronary Atherosclerosis
Background: Cleavage factor Im25 (CFIm25) regulates cell function by affecting mRNA editing processes and plays diverse roles in various diseases. Studies have found that peripheral blood monocytes are valuable in diagnosing and prognosing coronary atherosclerosis. However, no studies have examined the predictive value of CFIm25 expression in peripheral blood monocytes for coronary atherosclerosis.
- 1 January 2024
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 21 (3) , 562-570
Open AccessPredictive Value of CFIm25 Expression in Peripheral Blood Monocytes for Coronary Atherosclerosis
Background: Cleavage factor Im25 (CFIm25) regulates cell function by affecting mRNA editing processes and plays diverse roles in various diseases. Studies have found that peripheral blood monocytes are valuable in diagnosing and prognosing coronary atherosclerosis. However, no studies have examined the predictive value of CFIm25 expression in peripheral blood monocytes for coronary atherosclerosis.
- 7 December 2023
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 17 (3) , 648-656
T-cell Immunoglobulin and Mucin Domain 3 in Circulating Monocytes as a Novel Biomarker for Coronary Artery Disease
The diagnostic role of T-cell immunoglobulin and mucin domain 3 (Tim-3) expression levels in circulating monocytes in coronary artery disease (CAD) remains to be determined. Here, we enrolled of 265 patients and isolated circulating monocytes from the blood of all participants. We found that the Tim-3 expression levels in monocytes were lower in CAD patients than in the control group. Spearman correlation analysis verified that the Tim-3 levels in monocytes were negatively correlated with the Gensini score and the number of coronary vessels. Multivariate logistic regression analysis showed that the Tim-3 levels in circulating monocytes were negatively correlated with CAD, severe CAD, and three-vessel CAD. The ROC curve showed that Tim-3 possessed high diagnostic value for CAD, severe CAD, and three-vessel CAD, with CAD prediction being the most significant of these values. In conclusion, Tim-3 in circulating monocytes is a novel biomarker for CAD. Graphical Abstract T-cell immunoglobulin and mucin domain 3 (Tim-3) in circulating monocytes as a novel biomarker for coronary artery disease.
- 7 December 2023
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 17 (3) , 648-656
T-cell Immunoglobulin and Mucin Domain 3 in Circulating Monocytes as a Novel Biomarker for Coronary Artery Disease
The diagnostic role of T-cell immunoglobulin and mucin domain 3 (Tim-3) expression levels in circulating monocytes in coronary artery disease (CAD) remains to be determined. Here, we enrolled of 265 patients and isolated circulating monocytes from the blood of all participants. We found that the Tim-3 expression levels in monocytes were lower in CAD patients than in the control group. Spearman correlation analysis verified that the Tim-3 levels in monocytes were negatively correlated with the Gensini score and the number of coronary vessels. Multivariate logistic regression analysis showed that the Tim-3 levels in circulating monocytes were negatively correlated with CAD, severe CAD, and three-vessel CAD. The ROC curve showed that Tim-3 possessed high diagnostic value for CAD, severe CAD, and three-vessel CAD, with CAD prediction being the most significant of these values. In conclusion, Tim-3 in circulating monocytes is a novel biomarker for CAD. Graphical Abstract T-cell immunoglobulin and mucin domain 3 (Tim-3) in circulating monocytes as a novel biomarker for coronary artery disease.
- 27 September 2022
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 730, 109415
Sacubitril/valsartan attenuates myocardial ischemia/reperfusion injury via inhibition of the GSK3β/NF-κB pathway in cardiomyocytes
- 27 September 2022
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 730, 109415
Sacubitril/valsartan attenuates myocardial ischemia/reperfusion injury via inhibition of the GSK3β/NF-κB pathway in cardiomyocytes
- 24 September 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 50, 661-669
Outcomes of atrial fibrillation in patients with COVID-19 pneumonia: A systematic review and meta-analysis
- 24 September 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 50, 661-669
Outcomes of atrial fibrillation in patients with COVID-19 pneumonia: A systematic review and meta-analysis
- 1 April 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 42, 23-30
Outcomes of new-onset atrial fibrillation in patients with sepsis: A systematic review and meta-analysis of 225,841 patients
- 1 April 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 42, 23-30
Outcomes of new-onset atrial fibrillation in patients with sepsis: A systematic review and meta-analysis of 225,841 patients